A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration‐resistant metastatic prostate cancer

ADVERSE EVENT: Decreased abiraterone exposure after introducing carbamazepine. DRUGS IMPLICATED: Abiraterone acetate and carbamazepine. THE PATIENT: A 65‐year‐old man with metastatic castration resistant prostate cancer, was treated with abiraterone acetate and prednisolone, and received concomitant...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Clin Pharmacol
Main Authors: Benoist, Guillemette E., van der Doelen, Maarten J., ter Heine, Rob, van Erp, Nielka P., Mehra, Niven
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2018
Assuntos:
Case Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5903233/
https://ncbi.nlm.nih.gov/pubmed/29384591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13532
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares